Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
- PMID: 16741700
- DOI: 10.1007/s00134-006-0204-8
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
Abstract
Objective: The immediate overwhelming release of inflammatory mediators in septic shock is rapidly followed by strong anti-inflammatory responses inducing a state of immunosuppression. The patients who survive the initial hyper-inflammatory step of septic shock but subsequently die may be those who do not recover from immunosuppression. We assessed whether a low monocyte human leukocyte antigen-DR (mHLA-DR) expression, proposed as a marker of immunosuppression, is an independent predictor of mortality in patients who survived the initial 48 h of septic shock.
Design and setting: Prospective observational study performed in two adult intensive care units at a university hospital.
Patients: 93 consecutive patients with septic shock.
Measurements and results: At days 1-2, mHLA-DR values (determined by flow cytometry) were not significantly different between survivors and non-survivors. A sharp difference became highly significant at days 3-4 when survivors had increased their values, while non-survivors had not (43% vs. 18%, percentage of HLA-DR positive monocyte, p < 0.001). Multivariate logistic regression analysis revealed that low mHLA-DR (< 30%) at days 3-4 remained independently associated with mortality after adjustment for usual clinical confounders, adjusted odds ratio (CI): 6.48 (95% CI: 1.62-25.93).
Conclusion: The present preliminary results show that mHLA-DR is an independent predictor of mortality in septic shock patients. Being a marker of immune failure, low mHLA-DR may provide a rationale for initiating therapy to reverse immunosuppression. After validation of the current results in multicenter studies, mHLA-DR may help to stratify patients when designing a mediator-directed therapy in a time-dependent manner.
Similar articles
-
Prolonged suppression of monocytic human leukocyte antigen-DR expression correlates with mortality in pediatric septic patients in a pediatric tertiary Intensive Care Unit.J Crit Care. 2016 Jun;33:84-9. doi: 10.1016/j.jcrc.2016.01.027. Epub 2016 Feb 10. J Crit Care. 2016. PMID: 26928303
-
Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock.Crit Care Med. 2007 Aug;35(8):1910-7. doi: 10.1097/01.CCM.0000275271.77350.B6. Crit Care Med. 2007. PMID: 17568330
-
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma.Crit Care. 2010;14(6):R208. doi: 10.1186/cc9331. Epub 2010 Nov 19. Crit Care. 2010. PMID: 21092108 Free PMC article.
-
Poor Outcome Could Be Predicted by Lower Monocyte Human Leukocyte Antigen-DR Expression in Patients with Complicated Intra-Abdominal Infections: A Review.Surg Infect (Larchmt). 2020 Mar;21(2):77-80. doi: 10.1089/sur.2019.050. Epub 2019 Sep 4. Surg Infect (Larchmt). 2020. PMID: 31483200 Review.
-
Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis.Front Immunol. 2023 Feb 7;14:1130214. doi: 10.3389/fimmu.2023.1130214. eCollection 2023. Front Immunol. 2023. PMID: 36825018 Free PMC article. Review.
Cited by
-
The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.BMC Infect Dis. 2016 Sep 15;16:488. doi: 10.1186/s12879-016-1823-5. BMC Infect Dis. 2016. PMID: 27633969 Free PMC article.
-
The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.Crit Care. 2013 Jan 17;17(1):R8. doi: 10.1186/cc11932. Crit Care. 2013. PMID: 23327199 Free PMC article. Clinical Trial.
-
Innate Lymphocyte Th1 and Th17 Responses in Elderly Hospitalised Patients with Infection and Sepsis.Vaccines (Basel). 2020 Jun 17;8(2):311. doi: 10.3390/vaccines8020311. Vaccines (Basel). 2020. PMID: 32560376 Free PMC article.
-
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.Am J Respir Crit Care Med. 2020 Dec 1;202(11):1509-1519. doi: 10.1164/rccm.202005-1885OC. Am J Respir Crit Care Med. 2020. PMID: 32866033 Free PMC article.
-
Mice Survival and Plasmatic Cytokine Secretion in a "Two Hit" Model of Sepsis Depend on Intratracheal Pseudomonas Aeruginosa Bacterial Load.PLoS One. 2016 Aug 30;11(8):e0162109. doi: 10.1371/journal.pone.0162109. eCollection 2016. PLoS One. 2016. PMID: 27574993 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials